Untangling ccRCC prognosis with SLINKY.
作者信息
Reinfeld Bradley I, Rathmell W Kimryn
机构信息
Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
出版信息
Oncotarget. 2017 Mar 21;8(12):18620-18621. doi: 10.18632/oncotarget.15536.
Abstract
摘要
相似文献
1
Untangling ccRCC prognosis with SLINKY.利用SLINKY解析肾透明细胞癌的预后
Oncotarget. 2017 Mar 21;8(12):18620-18621. doi: 10.18632/oncotarget.15536.
2
Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.新型长链非编码RNA SLINKY是肾癌的一种预后生物标志物。
Oncotarget. 2017 Mar 21;8(12):18657-18669. doi: 10.18632/oncotarget.15703.
3
Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.长链非编码 RNA PVT1 的上调预示着透明细胞肾细胞癌患者的预后不良。
Cancer Biomark. 2017 Dec 12;21(1):55-63. doi: 10.3233/CBM-170251.
4
Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.鉴定透明细胞肾细胞癌中与糖酵解相关的 lncRNA 预后特征。
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20211451.
5
Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.长链非编码 RNA ENSG00000241684 的下调与晚期透明细胞肾细胞癌的不良预后相关。
Eur J Surg Oncol. 2018 Jun;44(6):840-846. doi: 10.1016/j.ejso.2018.01.013. Epub 2018 Jan 13.
6
Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.全基因组筛选和队列验证鉴定新型 lncRNAs 作为透明细胞肾细胞癌的预后生物标志物。
J Cell Biochem. 2020 Mar;121(3):2559-2570. doi: 10.1002/jcb.29478. Epub 2019 Oct 23.
7
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.构建具有预后意义的新型免疫相关 lncRNA 对用于肾透明细胞肾细胞癌。
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
8
Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.长链非编码RNA在透明细胞肾细胞癌中的预后意义：一项荟萃分析。
Medicine (Baltimore). 2019 Oct;98(40):e17276. doi: 10.1097/MD.0000000000017276.
9
Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.长链非编码 RNA PENG 通过海绵吸附 miR-15b 上调 PDZK1 表达，抑制肾透明细胞癌细胞增殖。
Oncogene. 2020 May;39(22):4404-4420. doi: 10.1038/s41388-020-1297-1. Epub 2020 Apr 27.
10
The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma.长链非编码 RNA Fer1L4 是肾透明细胞癌的一个不良预后参数。
Clin Transl Oncol. 2020 Sep;22(9):1524-1531. doi: 10.1007/s12094-020-02291-0. Epub 2020 Jan 21.
本文引用的文献
1
Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.新型长链非编码RNA SLINKY是肾癌的一种预后生物标志物。
Oncotarget. 2017 Mar 21;8(12):18657-18669. doi: 10.18632/oncotarget.15703.
2
Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough?肾细胞癌的辅助治疗：我们终于取得重大突破了吗？
Clin Adv Hematol Oncol. 2016 Nov;14(11):907-914.
3
Aberrant hnRNP K expression: All roads lead to cancer.异常的异质性核糖核蛋白K表达：条条大路通癌症。
Cell Cycle. 2016 Jun 17;15(12):1552-7. doi: 10.1080/15384101.2016.1164372.
4
Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression.交替代谢程序定义了肾细胞癌进展中相关生物学特征的区域差异。
Clin Cancer Res. 2016 Jun 15;22(12):2950-9. doi: 10.1158/1078-0432.CCR-15-2115. Epub 2016 Jan 19.
5
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.通过BAP1和PBRM1表达鉴定的透明细胞肾细胞癌亚型
J Urol. 2016 Jan;195(1):180-7. doi: 10.1016/j.juro.2015.07.113. Epub 2015 Aug 20.
6
ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.ClearCode34：一种局限性透明细胞肾细胞癌的预后风险预测指标。
Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035. Epub 2014 Feb 25.
Zotero 插件